BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19101805)

  • 1. Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D.
    Kibria G; Roni MA; Absar MS; Jalil RU
    AAPS PharmSciTech; 2008; 9(4):1240-6. PubMed ID: 19101805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution stability studies of suspensions of prolonged-release diclofenac microcapsules prepared by the Wurster process: I. Eudragit-based formulation and possible drug-excipient interaction.
    Adeyeye MC; Mwangi E; Katondo B; Jain A; Ichikawa H; Fukumori Y
    J Microencapsul; 2005 Jun; 22(4):333-42. PubMed ID: 16214782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique.
    Kibria G; Ul-Jalil R
    Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
    Zhu Y; Mehta KA; McGinity JW
    Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the drug release and surface morphological properties of film-coated pellets, and physical, thermal and mechanical properties of free films as a function of various curing conditions.
    Bhattacharjya S; Wurster DE
    AAPS PharmSciTech; 2008; 9(2):449-57. PubMed ID: 18431665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.
    Wu C; McGinity JW
    AAPS PharmSciTech; 2001 Nov; 2(4):24. PubMed ID: 14727861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films.
    Kramar A; Turk S; Vrecer F
    Int J Pharm; 2003 Apr; 256(1-2):43-52. PubMed ID: 12695010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of curing conditions and plasticizer level on the release of highly lipophilic drug from coated multiparticulate drug delivery system.
    Hamed E; Sakr A
    Pharm Dev Technol; 2003; 8(4):397-407. PubMed ID: 14601964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal treating as a tool to produce plastic pellets based on Eudragit RS PO and RL PO aimed for tableting.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2007 Aug; 67(1):260-7. PubMed ID: 17337169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control and stability of drug release from diffusion pellets coated with the aqueous quaternary polymethacrylate dispersion Eudragit RS 30 D.
    Lippold BC; Monells Pagés R
    Pharmazie; 2001 Jun; 56(6):477-83. PubMed ID: 11446169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of sustained-release doxazosin mesylate pellets.
    Ha JM; Kim JY; Oh TO; Rhee YS; Chi SC; Kuk H; Park CW; Park ES
    Chem Pharm Bull (Tokyo); 2013; 61(4):371-8. PubMed ID: 23385960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When drugs plasticize film coatings: Unusual formulation effects observed with metoprolol and Eudragit RS.
    Karrout Y; Siepmann F; Benzine Y; Paccou L; Guinet Y; Hedoux A; Siepmann J
    Int J Pharm; 2018 Mar; 539(1-2):39-49. PubMed ID: 29337184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of polymeric dispersion type on the release of diclofenac sodium from coated pellets].
    Krejcová K; Rabisková M; Vetchý D; Tomásek V; Prokopová A
    Ceska Slov Farm; 2007 Jul; 56(4):190-9. PubMed ID: 17969318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery.
    Shen X; Yu D; Zhu L; Branford-White C; White K; Chatterton NP
    Int J Pharm; 2011 Apr; 408(1-2):200-7. PubMed ID: 21291969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
    Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW
    J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying a novel electrostatic dry powder coating technology to pellets.
    Yang Q; Ma Y; Zhu J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry powder coating of pellets with micronized Eudragit RS for extended drug release.
    Pearnchob N; Bodmeier R
    Pharm Res; 2003 Dec; 20(12):1970-6. PubMed ID: 14725361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.